All In Biotech

Free tool

FAERS Monitor: Fintepla

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212102 or its brand name (Fintepla, Fenfluramine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,252

Serious

4,328

82% of reports

Hospitalization

1,529

Death reported

135

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure2,298
  • drug ineffective795
  • tricuspid valve incompetence722
  • off label use610
  • decreased appetite593
  • somnolence502
  • weight decreased491
  • mitral valve incompetence424
  • fatigue372
  • diarrhoea334
  • generalised tonic-clonic seizure290
  • hospitalisation276
  • pneumonia264
  • pulmonary valve incompetence259
  • insomnia222

Reports by year received

View as table
YearReports
20044
20055
20061
20076
20082
20091
20102
20112
20122
20133
20151
20163
20173
20184
201911
202044
2021451
2022743
2023602
2024910
20251,357
20261,095

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,907 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary valve incompetenceSignal259862.9756.5182,768
tricuspid valve incompetenceSignal722400.1372.4261,051
mitral valve incompetenceSignal424155.9142.062,697
seizureSignal2,29881.378.8179,476
generalised tonic-clonic seizureSignal29071.463.819,728
decreased appetiteSignal59310.29.54,982
somnolenceSignal50210.09.24,090
hospitalisationSignal2767.26.41,477
weight decreasedSignal4917.16.52,575
insomniaSignal2223.32.9366
pneumoniaSignal2643.32.9419
off label useSignal6102.82.6729
drug ineffectiveSignal7952.42.3702
diarrhoeaSignal3342.11.9190
fatigue3721.91.7168

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.